Loading chat...
PA HB561
Bill
Status
5/14/2025
Primary Sponsor
Maureen Madden
Click for details
AI Summary
-
Converts the Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program into a permanent Medication-Assisted Substance Abuse Treatment Grant Program, expanding eligible treatments beyond nonnarcotic options to include all FDA-approved medications for substance use disorders
-
Transfers program administration from the Department of Corrections to the Pennsylvania Commission on Crime and Delinquency, which will collaborate with the department on implementation
-
Expands treatment eligibility to include offenders while incarcerated, not just upon release, and covers those on probation with restrictive conditions rather than only county intermediate punishment sentences
-
Requires Medicaid managed care plans to approve medication-assisted treatment for program enrollees using drugs from the Department of Human Services' Uniform Statewide Preferred Drug List that do not require prior authorization
-
Mandates biennial reports to the General Assembly (starting two years after enactment) on program effectiveness, including treatment numbers, completion rates, recidivism data, grant summaries, and cost savings analysis
Legislative Description
In Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.
Last Action
Referred to Judiciary
5/22/2025